Eisai Co., Ltd. (ESAIY) Financials
ESAIY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 9.1 billion | 3.3 billion |
| Dec. 31, 2025 | 9.5 billion | 3.6 billion |
| Sept. 30, 2025 | 9.9 billion | 3.8 billion |
| June 30, 2025 | 9.8 billion | 3.9 billion |
ESAIY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -13.8 million | ? |
| Dec. 31, 2025 | 212.7 million | ? |
| Sept. 30, 2025 | 162.7 million | ? |
| June 30, 2025 | -55.6 million | ? |
ESAIY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | -20.7 million |
| Dec. 31, 2025 | 111.6 million |
| Sept. 30, 2025 | 69.8 million |
| June 30, 2025 | 100.9 million |
ESAIY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 1.5 billion | 847.4 million | - |
| Dec. 31, 2025 | 2.0 billion | 860.8 million | - |
| Sept. 30, 2025 | 2.1 billion | 925.0 million | - |
| June 30, 2025 | 2.0 billion | 694.3 million | - |
ESAIY Shares Outstanding
ESAIY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 31.7 million | 280.1 million | 762.1 million | - |
| Dec. 31, 2025 | 21.7 million | 254.7 million | 726.0 million | - |
| Sept. 30, 2025 | 14.7 million | 252.5 million | 714.0 million | - |
| June 30, 2025 | 63.2 million | 270.3 million | 698.0 million | - |
ESAIY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 1.3 billion | 331.6 million |
| Dec. 31, 2025 | 1.4 billion | 332.0 million |
| Sept. 30, 2025 | 1.4 billion | 313.0 million |
| June 30, 2025 | 1.4 billion | 296.9 million |
ESAIY
Price: $5.78
52 week price:
Earnings Per Share: 0.28 USD
P/E Ratio: 25.11
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 6.5 billion